Clinical Trials Logo

Anorexia clinical trials

View clinical trials related to Anorexia.

Filter by:

NCT ID: NCT05481736 Recruiting - Anorexia Nervosa Clinical Trials

Efficacy and Safety of COMP360 Psilocybin Therapy in Anorexia Nervosa: a Proof-of-concept Study

Start date: October 12, 2022
Phase: Phase 2
Study type: Interventional

Efficacy and Safety of COMP360 Psilocybin therapy in Anorexia Nervosa: a Proof-of-concept Study

NCT ID: NCT05477537 Not yet recruiting - Anorexia Nervosa Clinical Trials

Adapted Physical Activity in the Treatment of Anorexia: a Randomised Control Trial

EfAPA
Start date: January 2023
Phase: N/A
Study type: Interventional

People with anorexia nervosa are known to engage in significant physical activity or sports. This practice is problematic because of the state of malnutrition, its interference with re-nutrition and the somatic and nutritional complications that the effect of physical activity can cause in these people. This significant physical activity is also called hyperactivity in the literature, it is in fact a problematic use of physical activity, it is a symptom commonly observed in people suffering from anorexia nervosa (in 31 to 80% cases). In this context, Ms. Kern lecturer in Sciences and Techniques of Physical and Sports Activities (STAPS) at the University of Paris Nanterre has developed in collaboration with the clinical team (Pre Godart) an adapted physical activity program (APA) , for patients suffering from anorexia nervosa. The APA program includes 8 sessions of 1h30 including an important part of psychoeducation. The effectiveness of this program will be evaluated in terms of both restoration of body mass index and improvement in overall health. The project's hypothesis is that adding a standardized 8-week Adapted Physical Activity program to the usual care, including psychoeducation on both problematic physical activity and the consequences in terms of good practice of physical activity leads to a better outcome of overall care in people with anorexia nervosa.

NCT ID: NCT05446038 Completed - Anorexia Nervosa Clinical Trials

Multifamily Guided Self-Help Family-Based Treatment (MF-GSH-FBT)

MF-GSH-FBT
Start date: March 1, 2022
Phase: N/A
Study type: Interventional

This is a study testing whether an online Multifamily Guided Self-Help Family Based Treatment (FBT) for Anorexia Nervosa in adolescents aged 12 to 17 is acceptable and useful to families. This online Multifamily Guided Self-Help version of FBT consists of 12 weekly 60-minute telemedicine groups made up of parents from 4-5 families of young people with AN, coupled with access to an online guided self-help platform over the course of 6 months. The feasibility of online Guided Self-Help Family-Based Treatment for Anorexia is unknown, and the investigators hope to identify an adequate treatment for those who do not have access to in-person FBT.

NCT ID: NCT05418270 Completed - Aging Clinical Trials

Anorexia and Personality Traits in Elderly Individuals

APETI
Start date: June 2, 2022
Phase:
Study type: Observational

The aim of this study is to evaluate the relationship between age-related anorexia and personality traits in elderly individuals with comorbidities.

NCT ID: NCT05418075 Recruiting - Clinical trials for Anorexia in Adolescence

Evaluation of the Effectiveness of Add-on Hometreatment to Family Based Therapy in Adolescent Anorexia Nervosa.

HTED
Start date: February 1, 2022
Phase: N/A
Study type: Interventional

The project serves to evaluate a new treatment method with outreach services as a supplement to family-based therapy in the treatment of children and adolescents with eating disorders. The project is intended to help identify different family structures and which families will benefit most from the new outreach service of home-based treatment.

NCT ID: NCT05416697 Recruiting - Malnutrition Clinical Trials

Effectiveness of Cannabinoids on Appetite in Scleroderma

Start date: November 9, 2022
Phase: Phase 3
Study type: Interventional

The cannabinoid has benefits in many aspects but the evidence of the effect of cannabinoids in humans with SSc is limited. We, therefore, would like to investigate the efficacy of cannabinoids on the appetite, sleep efficiency, quality of life, pain, and critical cytokine level in SSc compared with placebo in SSc patients and the adverse events associated with cannabinoids in those patients.

NCT ID: NCT05389657 Active, not recruiting - Anorexia Nervosa Clinical Trials

Optimizing Provider Training in Eating Disorders (OPTED)

OPTED
Start date: July 14, 2022
Phase: N/A
Study type: Interventional

This is a randomized controlled trial for mental health clinicians comparing two methods of training in family-based treatment (FBT) for restrictive eating disorders.

NCT ID: NCT05380479 Recruiting - Anorexia Clinical Trials

Mirtazapine Versus Megestrol Acetate in Treatment of Anorexia-cachexia in Advanced Cancer Patients.

Start date: June 1, 2022
Phase: Phase 2
Study type: Interventional

This study was 8 weeks randomized, double-blind trail to assess the effect of mirtazapine versus megestrol acetate in treatment of anorexia-cachexia in advanced cancer patients in 80 patients. Participants were assessed at baseline, 4 weeks and 8 weeks. Subject were randomized to receive either mirtazapine 15 mg tablet daily or megestrol acetate 160 mg tablet daily for 8 weeks. The primary outcome was the measure of FAACT(A/C) score and the secondary measure includes weight, BMI, quality of life and evaluate adverse effects.

NCT ID: NCT05368844 Recruiting - Anorexia Nervosa Clinical Trials

Transcranial Magnetic Stimulation (TMS) in the Treatment of Anorexia Nervosa

Start date: June 16, 2022
Phase: N/A
Study type: Interventional

Anorexia nervosa is a severe psychiatric disorder associated with food avoidance and body image distortion, that is feeling fat despite being underweight. It is the third most common chronic illness among adolescent females, and its mortality reaches its peak between the ages 16 and 29 years old. There are very few treatments for anorexia nervosa and especially no biological treatments have been approved. Recent brain imaging research has repeatedly implicated brain circuits that include the insula in the disorder. The insula is a brain region important in taste processing as well as in the integration of body perception and has strong connections to the brain reward system. Transcranial magnetic stimulation (TMS) is a relatively new methodology that has been shown to alter neurocircuitry and alleviate depression. Here, the study goal is to develop TMS as a methodology to change altered neurocircuitry in anorexia nervosa and alleviate disorder specific behaviors.

NCT ID: NCT05362981 Active, not recruiting - Anorexia Nervosa Clinical Trials

Contra-attitudinal Versus Mindfulness Treatment in Anorexia Nervosa Controlled Trial

CAT-AN
Start date: April 1, 2022
Phase: N/A
Study type: Interventional

This study propose to compare the effectiveness of two care programs, the CAT and cognitive therapy based on mindfulness (Mindfulness-Based Cognitive Therapy, MBCT) compared to the usual care ("Treated as usual", TAU) in AM and to show their benefit on dimensions specific to EDs such as body dissatisfaction and the internalization of the ideal of thinness, but also on eating symptoms and the anxious and depressive dimensions.